FDA approves a new acne gel

Filed in archive Treatment on July 22, 2005

A new acne gel received FDA approval. It is dapsone-based, which is different from the standard antibiotic regimen for acne:

Aczone was tested in two clinical trials with more than 3,000 acne patients aged 12 and older. It was compared with a similar gel without dapsone.

Aczone fared better than the comparison gel. After three months, Aczone reduced more pimples.

Women tended to have more success and fewer pimples with Aczone than men.

That trial seemed odd to me, although I haven't read it myself. Would have been more helpful to compare it to the standard treatments. (Hitti, "New Acne Gel Gets FDA Approval", WebMD, Jul.21)